Leading the Way in Oncology Insights

Resources highlighting oncology data trends and company announcements.

Articles and Press Releases

  • MiBA and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

    PALO ALTO, Calif., and TAMPA, Fla., December 20, 2024 — Guardant Health, Inc. (Nasdaq: GH) and Meaningful Insights Biotech Analytics (MiBA) today announced a unique partnership aimed at optimizing the use of biomarker testing and data analytics to advance precision medicine in patient care throughout the MiBA Network.

    Read Now

  • Joint Press Release: MiBA and NCODA Partner to Launch Oncology Insights Program

    Tampa, FL & Cazenovia, NY October 22, 2024 – Meaningful Insights Biotech Analytics, LLC (MiBA) and the National Community Oncology Dispensing Association (NCODA) are pleased to announce their partnership on the launch of the Oncology Insights Program (OIP), an innovative and educational initiative powered by prescriber data.

    Read Now

  • Introducing MiBA and How We Drive Informed Decision Making to Improve Patient Outcomes

    At MiBA, we never lose sight of what matters most - the patient. We're a revolutionary healthcare technology company redefining the landscape of patient care and medical research. Our mission is to advance healthcare quality through actionable, data-centered intelligence, bridging gaps and empowering better outcomes for all stakeholders in the healthcare ecosystem.

    Read Now
  • MiBA + Foundation Medicine

    MiBA and Foundation Medicine Partner to Advance Genomic Profiling Utilization in Cancer Care

    Meaningful Insights Biotech Analytics (MiBA), announced a unique partnership with Foundation Medicine, Inc. to expand awareness of and education on comprehensive genomic profiling (CGP) in the community oncology setting.

    Read Now

  • MiBA: Pioneering Data-Driven Oncology Insights for a Healthier Tomorrow

    Meaningful Insights Biotech Analytics (MiBA), a trailblazing healthcare technology company, officially announces its launch, offering innovative data analytics solutions to transform oncology care and research.

    Read Now

  • Cellectar Biosciences Partners with MiBA

    Partnership to Provide Key Data on WM Treatment Landscape and Community Clinic Access to Support Iopofosine I 131 Commercialization Strategy

    Read Now

Together, we can turn data into breakthroughs.

Contact us for a personalized demonstration and discover how our platform can revolutionize your approach to cancer research and patient care.